Study shows how NSAIDs exacerbate C. difficile infections

FHS
July 19, 2023
6:40 pm

Why do nonsteroidal anti-inflammatory drugs (NSAIDs) exacerbate gastrointestinal infections by Clostridioides difficile, the leading cause of antibiotic-associated diarrhea worldwide?

Bristol Myers drops cell therapy pacts with Immatics, Century as part of portfolio review

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 17, 2024

Vendor Sprawl: The Hidden Barrier to Effective Patient Engagement

Aditya Bansod, Chief Technology Officer, Luma Health Patient engagement is a critical priority for modern healthcare organizations. Yet, the path is often obstructed by the

July 25, 2024

Fujifilm makes $200M manufacturing investment while Novartis pours $80M+ into China facility

Fujifilm Corporation is investing $200 million into two of its subsidiaries to expand its cell therapy contract development and manufacturing, the company announced Monday. The

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.